Hilmer SN

References (4)

Title : Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia - Ailabouni_2024_Drugs.Aging__
Author(s) : Ailabouni NJ , Thompson W , Hilmer SN , Quirke L , McNeece J , Bourke A , Furst C , Reeve E
Ref : Drugs & Aging , : , 2024
Abstract :
PubMedSearch : Ailabouni_2024_Drugs.Aging__
PubMedID: 39289289

Title : Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary - Reeve_2019_Med.J.Aust_210_174
Author(s) : Reeve E , Farrell B , Thompson W , Herrmann N , Sketris I , Magin PJ , Chenoweth L , Gorman M , Quirke L , Bethune G , Hilmer SN
Ref : Med J Aust , 210 :174 , 2019
Abstract :
PubMedSearch : Reeve_2019_Med.J.Aust_210_174
PubMedID: 30771226

Title : Current approaches to the pharmacological treatment of Alzheimer's disease - Garcia-Ptacek_2018_Aust.J.Gen.Pract_47_586
Author(s) : Garcia-Ptacek S , Bell JS , Tan EC , Hilmer SN
Ref : Aust J Gen Pract , 47 :586 , 2018
Abstract :
PubMedSearch : Garcia-Ptacek_2018_Aust.J.Gen.Pract_47_586
PubMedID: 30244564

Title : Anticholinergic component of the drug burden index and the anticholinergic drug scale as measures of anticholinergic exposure in older people in new zealand: a population-level study - Narayan_2013_Drugs.Aging_30_927
Author(s) : Narayan SW , Hilmer SN , Horsburgh S , Nishtala PS
Ref : Drugs & Aging , 30 :927 , 2013
Abstract :
PubMedSearch : Narayan_2013_Drugs.Aging_30_927
PubMedID: 23975730